In 'advanced' settlement talks, Teva sets aside $200M to resolve US price-fixing probe

Teva has long maintained its innocence in the face of a far-reaching price-fixing indictment by the U.S. Department of Justice (DOJ). Now, the company is earmarking a sizable chunk of cash in an attempt to put the charges to bed.